152 related articles for article (PubMed ID: 32243586)
1. Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort.
Idahl A; Le Cornet C; González Maldonado S; Waterboer T; Bender N; Tjønneland A; Hansen L; Boutron-Ruault MC; Fournier A; Kvaskoff M; Boeing H; Trichopoulou A; Valanou E; Peppa E; Palli D; Agnoli C; Mattiello A; Tumino R; Sacerdote C; Onland-Moret NC; Gram IT; Weiderpass E; Quirós JR; Duell EJ; Sánchez MJ; Chirlaque MD; Barricarte A; Gil L; Brändstedt J; Riesbeck K; Lundin E; Khaw KT; Perez-Cornago A; Gunter MJ; Dossus L; Kaaks R; Fortner RT
Int J Cancer; 2020 Oct; 147(8):2042-2052. PubMed ID: 32243586
[TBL] [Abstract][Full Text] [Related]
2. Sexually Transmitted Infections and Risk of Epithelial Ovarian Cancer: Results From the Finnish Maternity Cohort.
Skarga E; Surcel HM; Kaaks R; Waterboer T; Fortner RT
J Infect Dis; 2023 Nov; 228(11):1621-1629. PubMed ID: 37196097
[TBL] [Abstract][Full Text] [Related]
3. Sexually transmitted infections and risk of epithelial ovarian cancer: results from the Nurses' Health Studies.
Fortner RT; Terry KL; Bender N; Brenner N; Hufnagel K; Butt J; Waterboer T; Tworoger SS
Br J Cancer; 2019 Apr; 120(8):855-860. PubMed ID: 30894687
[TBL] [Abstract][Full Text] [Related]
4. Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort.
Castellsagué X; Pawlita M; Roura E; Margall N; Waterboer T; Bosch FX; de Sanjosé S; Gonzalez CA; Dillner J; Gram IT; Tjønneland A; Munk C; Pala V; Palli D; Khaw KT; Barnabas RV; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Fagherazzi G; Kaaks R; Lukanova A; Steffen A; Trichopoulou A; Trichopoulos D; Klinaki E; Tumino R; Sacerdote C; Mattiello A; Bueno-de-Mesquita HB; Peeters PH; Lund E; Weiderpass E; Quirós JR; Sánchez MJ; Navarro C; Barricarte A; Larrañaga N; Ekström J; Hortlund M; Lindquist D; Wareham N; Travis RC; Rinaldi S; Tommasino M; Franceschi S; Riboli E
Int J Cancer; 2014 Jul; 135(2):440-52. PubMed ID: 24338606
[TBL] [Abstract][Full Text] [Related]
5. Chlamydia trachomatis, Pelvic Inflammatory Disease, and Epithelial Ovarian Cancer.
Paavonen J; Turzanski Fortner R; Lehtinen M; Idahl A
J Infect Dis; 2021 Aug; 224(12 Suppl 2):S121-S127. PubMed ID: 34396414
[TBL] [Abstract][Full Text] [Related]
6. Identifying a consensus sample type to test for Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Trichomonas vaginalis and human papillomavirus.
Coorevits L; Traen A; Bingé L; Van Dorpe J; Praet M; Boelens J; Padalko E
Clin Microbiol Infect; 2018 Dec; 24(12):1328-1332. PubMed ID: 29559392
[TBL] [Abstract][Full Text] [Related]
7. Chlamydia trachomatis and Mycoplasma genitalium plasma antibodies in relation to epithelial ovarian tumors.
Idahl A; Lundin E; Jurstrand M; Kumlin U; Elgh F; Ohlson N; Ottander U
Infect Dis Obstet Gynecol; 2011; 2011():824627. PubMed ID: 21811380
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of 7 sexually transmitted organisms by multiplex real-time PCR in Fallopian tube specimens collected from Saudi women with and without ectopic pregnancy.
Ashshi AM; Batwa SA; Kutbi SY; Malibary FA; Batwa M; Refaat B
BMC Infect Dis; 2015 Dec; 15():569. PubMed ID: 26666587
[TBL] [Abstract][Full Text] [Related]
9. The vaginal microbiota and its association with human papillomavirus, Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium infections: a systematic review and meta-analysis.
Tamarelle J; Thiébaut ACM; de Barbeyrac B; Bébéar C; Ravel J; Delarocque-Astagneau E
Clin Microbiol Infect; 2019 Jan; 25(1):35-47. PubMed ID: 29729331
[TBL] [Abstract][Full Text] [Related]
10. The two-sided role of the vaginal microbiome in Chlamydia trachomatis and Mycoplasma genitalium pathogenesis.
Molenaar MC; Singer M; Ouburg S
J Reprod Immunol; 2018 Nov; 130():11-17. PubMed ID: 30149363
[TBL] [Abstract][Full Text] [Related]
11. Bacterial vaginosis-associated vaginal microbiota is an age-independent risk factor for Chlamydia trachomatis, Mycoplasma genitalium and Trichomonas vaginalis infections in low-risk women, St. Petersburg, Russia.
Shipitsyna E; Khusnutdinova T; Budilovskaya O; Krysanova A; Shalepo K; Savicheva A; Unemo M
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1221-1230. PubMed ID: 32036466
[TBL] [Abstract][Full Text] [Related]
12. Association of Chlamydia trachomatis infection and herpes simplex virus type 2 serostatus with genital human papillomavirus infection in men: the HPV in men study.
Alberts CJ; Schim van der Loeff MF; Papenfuss MR; da Silva RJ; Villa LL; Lazcano-Ponce E; Nyitray AG; Giuliano AR
Sex Transm Dis; 2013 Jun; 40(6):508-15. PubMed ID: 23680908
[TBL] [Abstract][Full Text] [Related]
13. Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations.
Trabert B; Waterboer T; Idahl A; Brenner N; Brinton LA; Butt J; Coburn SB; Hartge P; Hufnagel K; Inturrisi F; Lissowska J; Mentzer A; Peplonska B; Sherman ME; Wills GS; Woodhall SC; Pawlita M; Wentzensen N
J Natl Cancer Inst; 2019 Feb; 111(2):129-136. PubMed ID: 29790947
[TBL] [Abstract][Full Text] [Related]
14. Design of a multi-epitope protein vaccine against herpes simplex virus, human papillomavirus and Chlamydia trachomatis as the main causes of sexually transmitted diseases.
Dorosti H; Eskandari S; Zarei M; Nezafat N; Ghasemi Y
Infect Genet Evol; 2021 Dec; 96():105136. PubMed ID: 34775078
[TBL] [Abstract][Full Text] [Related]
15. Chlamydia trachomatis infection and HPV/Chlamydia trachomatis co-infection among HPV-vaccinated young women at the beginning of their sexual activity.
Bianchi S; Boveri S; Igidbashian S; Amendola A; Urbinati AM; Frati ER; Bottari F; Colzani D; Landoni F; Tanzi E; Sideri M; Sandri MT
Arch Gynecol Obstet; 2016 Nov; 294(6):1227-1233. PubMed ID: 27501926
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of the Frequency of Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis and Mycoplasma genitalium in Men Living with HIV in Terms of Sociodemographic Characteristics and Behavioral Risk Factors].
Ayaz ÇM; Karakaplan ND; İnkaya AÇ; Çakır B; Ünal S; Zarakolu P
Mikrobiyol Bul; 2023 Jul; 57(3):378-389. PubMed ID: 37462302
[TBL] [Abstract][Full Text] [Related]
17. Sexually transmissible infections and prostate cancer risk.
Huang WY; Hayes R; Pfeiffer R; Viscidi RP; Lee FK; Wang YF; Reding D; Whitby D; Papp JR; Rabkin CS
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2374-81. PubMed ID: 18768506
[TBL] [Abstract][Full Text] [Related]
18. Serologic evidence of past infection with Chlamydia trachomatis, in relation to ovarian cancer.
Ness RB; Goodman MT; Shen C; Brunham RC
J Infect Dis; 2003 Apr; 187(7):1147-52. PubMed ID: 12660930
[TBL] [Abstract][Full Text] [Related]
19. STI with Mycoplasma genitalium-more common than Chlamydia trachomatis in patients attending youth clinics in Sweden.
Nolskog P; Backhaus E; Nasic S; Enroth H
Eur J Clin Microbiol Infect Dis; 2019 Jan; 38(1):81-86. PubMed ID: 30327896
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalences of herpes simplex virus type 2, five oncogenic human papillomaviruses, and Chlamydia trachomatis in Katowice, Poland.
Görander S; Lagergård T; Romanik M; Viscidi RP; Martirosian G; Liljeqvist JA
Clin Vaccine Immunol; 2008 Apr; 15(4):675-80. PubMed ID: 18287578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
